Literature DB >> 17694194

Utility of judet oblique x-rays in preoperative assessment of acetabular periprosthetic osteolysis: a preliminary study.

Adrian Thomas1, Noah J Epstein, Kathryn Stevens, Stuart B Goodman.   

Abstract

Anteroposterior (AP) x-rays provide limited information about size and location of acetabular osteolytic lesions after total hip arthroplasty (THA). In the study reported here, we sought to determine the utility of oblique (Judet) x-rays in preoperative assessment of acetabular lesions. AP, anterior (obturator), and posterior (iliac oblique) x-rays of 10 patients (10 hips) who underwent revision THA were evaluated retrospectively. Mean osteolytic area was 790 mm2 (SD, 520 mm2) on anterior oblique x-rays and 384 mm2 (SD, 396 mm2) on AP x-rays (P = .005). Mean osteolytic area on posterior oblique x-rays was 512 mm2 (SD, 430 mm2) (P = .34). Judet x-rays were useful in determining size and location of acetabular osteolysis.

Entities:  

Mesh:

Year:  2007        PMID: 17694194

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  3 in total

Review 1.  Acetabular defect classification in times of 3D imaging and patient-specific treatment protocols.

Authors:  K Horas; J Arnholdt; A F Steinert; M Hoberg; M Rudert; B M Holzapfel
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

2.  Use of morphometry to quantify osteolysis after total hip arthroplasty.

Authors:  Lindsay K Smith; Fiona Cramp; Shea Palmer; Nikki Coghill; Robert F Spencer
Journal:  Clin Orthop Relat Res       Date:  2010-05-12       Impact factor: 4.176

Review 3.  The Diagnosis and Treatment of Acetabular Bone Loss in Revision Hip Arthroplasty: An International Consensus Symposium.

Authors:  Peter K Sculco; Timothy Wright; Michael-Alexander Malahias; Alexander Gu; Mathias Bostrom; Fares Haddad; Seth Jerabek; Michael Bolognesi; Thomas Fehring; Alejandro Gonzalez DellaValle; William Jiranek; William Walter; Wayne Paprosky; Donald Garbuz; Thomas Sculco
Journal:  HSS J       Date:  2021-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.